GWW vs KNSA · P/E 27, rev $9.76B vs P/E 53, rev $677.6M
WW Grainger Inc (GWW) versus Kiniksa Pharmaceuticals Ltd (KNSA) — a side-by-side from cached financials, not a winner call.
WW Grainger Inc (GWW) is a industrial distribution company listed on US.
Kiniksa Pharmaceuticals Ltd (KNSA) is a drug manufacturers - specialty & generic company listed on US.
Latest reported GWW revenue for 2026-06-30 was $9.76B. Net income was $1.13B. GWW currently screens at market cap $50.34B and trailing P/E 26.9.
Latest reported KNSA revenue for 2025-12-31 was $677.6M. Net income was $59.0M. Revenue was up 60.1% from 2024-12-31 to 2025-12-31. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
GWW currently screens at market cap $50.34B and trailing P/E 26.9. KNSA currently screens at market cap $3.73B and trailing P/E 53.2.
Not investment advice. Open the GWW and KNSA stock pages for the full models.
Not investment advice.